These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 3545529
1. Protection against disseminated intravascular coagulation and death by antithrombin-III in the Escherichia coli endotoxemic rat. Emerson TE, Fournel MA, Leach WJ, Redens TB. Circ Shock; 1987; 21(1):1-13. PubMed ID: 3545529 [Abstract] [Full Text] [Related]
3. Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremia. Emerson TE, Fournel MA, Redens TB, Taylor FB. Am J Med; 1989 Sep 11; 87(3B):27S-33S. PubMed ID: 2679067 [Abstract] [Full Text] [Related]
4. Antithrombin III replacement in animal models of acquired antithrombin III deficiency. Emerson TE. Blood Coagul Fibrinolysis; 1994 Jan 11; 5 Suppl 1():S37-45; discussion S59-64. PubMed ID: 8186355 [Abstract] [Full Text] [Related]
5. Effect of a platelet activating factor antagonist and antithrombin III on septicemia and endotoxemia in rats. Inoue Y, Kohno S, Miyazaki T, Yamaguchi K. Tohoku J Exp Med; 1991 Mar 11; 163(3):175-85. PubMed ID: 2063402 [Abstract] [Full Text] [Related]
6. Efficacy of antithrombin III in endotoxin-induced disseminated intravascular coagulation. Hauptman JG, Hassouna HI, Bell TG, Penner JA, Emerson TE. Circ Shock; 1988 Jun 11; 25(2):111-22. PubMed ID: 3390893 [Abstract] [Full Text] [Related]
7. Diagnosis and stage-related treatment of disseminated intravascular coagulation in meningococcal infections. Mertens R, Peschgens T, Granzen B, Heimann G. Klin Padiatr; 1999 Jun 11; 211(2):65-9. PubMed ID: 10407813 [Abstract] [Full Text] [Related]
8. Choline or CDP-choline attenuates coagulation abnormalities and prevents the development of acute disseminated intravascular coagulation in dogs during endotoxemia. Yilmaz Z, Ozarda Y, Cansev M, Eralp O, Kocaturk M, Ulus IH. Blood Coagul Fibrinolysis; 2010 Jun 11; 21(4):339-48. PubMed ID: 20410813 [Abstract] [Full Text] [Related]
9. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits]. Gómez C, Páramo JA, Rocha E. Sangre (Barc); 1992 Feb 11; 37(1):5-10. PubMed ID: 1585238 [Abstract] [Full Text] [Related]
10. Activation of the coagulation cascade in patients with leptospirosis. Chierakul W, Tientadakul P, Suputtamongkol Y, Wuthiekanun V, Phimda K, Limpaiboon R, Opartkiattikul N, White NJ, Peacock SJ, Day NP. Clin Infect Dis; 2008 Jan 15; 46(2):254-60. PubMed ID: 18171258 [Abstract] [Full Text] [Related]
11. Diagnosis of disseminated intravascular coagulation in dogs admitted to an intensive care unit. Bateman SW, Mathews KA, Abrams-Ogg AC, Lumsden JH, Johnstone IB, Hillers TK, Foster RA. J Am Vet Med Assoc; 1999 Sep 15; 215(6):798-804. PubMed ID: 10496131 [Abstract] [Full Text] [Related]
12. Monophosphoryl lipid A protects against endotoxic shock via inhibiting neutrophil infiltration and preventing disseminated intravascular coagulation. Yao Z, Foster PA, Gross GJ. Circ Shock; 1994 Jul 15; 43(3):107-14. PubMed ID: 7850930 [Abstract] [Full Text] [Related]
13. A comparison of haemocoagulation tests in the experimental endotoxin model DIC and in rats whole-body irradiated by 250 Gy. Hlousková D, Polívková J, Pospísil J, Kase F. Sb Lek; 1993 Jul 15; 94(1):31-8. PubMed ID: 7991995 [Abstract] [Full Text] [Related]
14. Synergistic protection from lung damage by combining antithrombin-III and alpha 1-proteinase inhibitor in the E. coli endotoxemic sheep pulmonary dysfunction model. Redens TB, Leach WJ, Bogdanoff DA, Emerson TE. Circ Shock; 1988 Sep 15; 26(1):15-26. PubMed ID: 3056631 [Abstract] [Full Text] [Related]
15. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III. Aoki Y, Ohishi R, Takei R, Matsuzaki O, Mohri M, Saitoh K, Gomi K, Sugihara T, Kiyota T, Yamamoto S. Thromb Haemost; 1994 Apr 15; 71(4):452-5. PubMed ID: 8052962 [Abstract] [Full Text] [Related]
16. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC]. Okajima K. Rinsho Byori; 1994 Jan 15; 42(1):45-55. PubMed ID: 8107283 [Abstract] [Full Text] [Related]
17. [Treatment effects of antithrombin-III on coagulation abnormalities in rats with endotoxaemia]. Qiao YJ, Zhu JM, You XL, Zhang Y. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Mar 15; 19(3):165-7. PubMed ID: 17376272 [Abstract] [Full Text] [Related]
18. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits. Bregengård C, Nordfang O, Wildgoose P, Svendsen O, Hedner U, Diness V. Blood Coagul Fibrinolysis; 1993 Oct 15; 4(5):699-706. PubMed ID: 8292719 [Abstract] [Full Text] [Related]
19. Endotoxin-induced intravascular coagulation (DIC) and its therapy. Prager RL, Dunn EL, Kirsh MM, Penner JA. Adv Shock Res; 1979 Oct 15; 2():277-87. PubMed ID: 400581 [Abstract] [Full Text] [Related]
20. Reduction of mortality with antithrombin III in septicemic rats: a study of Klebsiella pneumoniae induced sepsis. Dickneite G, Pâques EP. Thromb Haemost; 1993 Feb 01; 69(2):98-102. PubMed ID: 8456437 [Abstract] [Full Text] [Related] Page: [Next] [New Search]